Cargando…

Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases

SIMPLE SUMMARY: Clinical management of colo-rectal liver metastasis would benefit from a refined stratification of patients in prognostic groups, in order to identify the best therapeutic option. Efforts are ongoing in the definition of parameters associated with clinical behaviors, which could help...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigamonti, Alessandra, Feuerhake, Friedrich, Donadon, Matteo, Locati, Massimo, Marchesi, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959473/
https://www.ncbi.nlm.nih.gov/pubmed/33802446
http://dx.doi.org/10.3390/cancers13051075
_version_ 1783664970024615936
author Rigamonti, Alessandra
Feuerhake, Friedrich
Donadon, Matteo
Locati, Massimo
Marchesi, Federica
author_facet Rigamonti, Alessandra
Feuerhake, Friedrich
Donadon, Matteo
Locati, Massimo
Marchesi, Federica
author_sort Rigamonti, Alessandra
collection PubMed
description SIMPLE SUMMARY: Clinical management of colo-rectal liver metastasis would benefit from a refined stratification of patients in prognostic groups, in order to identify the best therapeutic option. Efforts are ongoing in the definition of parameters associated with clinical behaviors, which could help classifying patients in clinically relevant groups. Here we aimed at discussing the recent advances in this field, and we introduced current and new promising candidates, such as morphological tumor features and immune components, which have been showing significant association with survival. Some of these parameters are slowly reaching the clinic and further efforts are ongoing in the attempt to combine them in multiparametric scores. ABSTRACT: Prognostic studies are increasingly providing new tools to stratify colo-rectal liver metastasis patients into clinical subgroups, with remarkable implications in terms of clinical management and therapeutic choice. Here, the strengths and hurdles of current prognostic tools in colo-rectal liver metastasis are discussed. Alongside more classic histopathological parameters, which capture features related to the tumor component, such as tumor invasion, tumor growth pattern and regression score, we will discuss immune mediators, which are starting to be considered important features. Their objective quantification has shown significant results in prognostication studies, with most of the work focused on adaptive immune cells, namely T cells. As for macrophages, they are only starting to be appreciated and we will present recent advances in evaluation of macrophage morphological features. Deeper knowledge acquired by multiparametric analyses is rapidly uncovering the variety of immune players that should be assessed. The future projection is to implement deep-learning histopathological tools and to integrate histopathological and immune metrics in multiparametric scores, with the ultimate objective to achieve a deeper resolution of the tumor features and their relevance for colo-rectal liver metastasis.
format Online
Article
Text
id pubmed-7959473
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79594732021-03-16 Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases Rigamonti, Alessandra Feuerhake, Friedrich Donadon, Matteo Locati, Massimo Marchesi, Federica Cancers (Basel) Review SIMPLE SUMMARY: Clinical management of colo-rectal liver metastasis would benefit from a refined stratification of patients in prognostic groups, in order to identify the best therapeutic option. Efforts are ongoing in the definition of parameters associated with clinical behaviors, which could help classifying patients in clinically relevant groups. Here we aimed at discussing the recent advances in this field, and we introduced current and new promising candidates, such as morphological tumor features and immune components, which have been showing significant association with survival. Some of these parameters are slowly reaching the clinic and further efforts are ongoing in the attempt to combine them in multiparametric scores. ABSTRACT: Prognostic studies are increasingly providing new tools to stratify colo-rectal liver metastasis patients into clinical subgroups, with remarkable implications in terms of clinical management and therapeutic choice. Here, the strengths and hurdles of current prognostic tools in colo-rectal liver metastasis are discussed. Alongside more classic histopathological parameters, which capture features related to the tumor component, such as tumor invasion, tumor growth pattern and regression score, we will discuss immune mediators, which are starting to be considered important features. Their objective quantification has shown significant results in prognostication studies, with most of the work focused on adaptive immune cells, namely T cells. As for macrophages, they are only starting to be appreciated and we will present recent advances in evaluation of macrophage morphological features. Deeper knowledge acquired by multiparametric analyses is rapidly uncovering the variety of immune players that should be assessed. The future projection is to implement deep-learning histopathological tools and to integrate histopathological and immune metrics in multiparametric scores, with the ultimate objective to achieve a deeper resolution of the tumor features and their relevance for colo-rectal liver metastasis. MDPI 2021-03-03 /pmc/articles/PMC7959473/ /pubmed/33802446 http://dx.doi.org/10.3390/cancers13051075 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rigamonti, Alessandra
Feuerhake, Friedrich
Donadon, Matteo
Locati, Massimo
Marchesi, Federica
Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases
title Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases
title_full Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases
title_fullStr Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases
title_full_unstemmed Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases
title_short Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases
title_sort histopathological and immune prognostic factors in colo-rectal liver metastases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959473/
https://www.ncbi.nlm.nih.gov/pubmed/33802446
http://dx.doi.org/10.3390/cancers13051075
work_keys_str_mv AT rigamontialessandra histopathologicalandimmuneprognosticfactorsincolorectallivermetastases
AT feuerhakefriedrich histopathologicalandimmuneprognosticfactorsincolorectallivermetastases
AT donadonmatteo histopathologicalandimmuneprognosticfactorsincolorectallivermetastases
AT locatimassimo histopathologicalandimmuneprognosticfactorsincolorectallivermetastases
AT marchesifederica histopathologicalandimmuneprognosticfactorsincolorectallivermetastases